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treated by OR or ER (P0.97). Late patient survival at
5-years was 784% for low-risk (SVS 9), 556% for
intermediate-risk (SVS 9-16), and 439% for high-risk
(SVS 16) categories.
Conclusions: Late mortality after mesenteric revascu-
larization for CMI was not influenced by the type of arterial
reconstruction. Age greater than 80 years old, dialysis, and
home oxygen therapy were independently associated with
increased risk of late death.
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SS7.
Percutaneous Transluminal Angioplasty/Stenting of
Renal Fibromuscular Dysplasia: Short and Long Term
Clinical Outcomes over Ten Year Period
Albeir Mousa, Patrick Stone, Mark Bates, Mike Borce,
Aravinda Nanjundappa, Ali AbuRahma. Vascular & Endo-
vascular Surgery Division, West Virginia University,
Charleston, WV
Objectives: To evaluate short and long term outcomes
of patients undergoing percutaneous transluminal angio-
plasty (PTA) with/out stent of renal artery fibromuscular
dysplasia (RAFMD).
Methods: Retrospective analysis of all patients with
renal artery RAFMD between January 1999 and December
2009 was performed. Blood pressure (BP) measurement,
number of BP medications and hypertension defined by
systolic SBP140/ diastolic DBP90were recorded.
Renal function was defined by estimated glomerular filtra-
tion rate (eGFR). Restenosis was defined by stenosis 60%
and was determined by renal artery duplex and/or angiog-
raphy. Freedom from event (restenosis, renal failure or
recurrent hypertension) was performed using Life Table
analysis.
Results: Forty-six procedures were performed on 35
patients with RAFMD. Thirty-two (91%) were female with
mean age of 62.9. Procedural success was 100% with ad-
junctive stent placement in 23.9% of patients. Short term
outcomes: The majority (66%) had an immediate clinical
benefit for hypertension, 6% were cured without BP med-
ications and 60% improved with less than or equal to
pre-operative BP medications. Post-intervention, 17% re-
mained at moderately reduced renal function (60), while
the percent above (60) eGFR increased significantly
(from 51 to 69%; p0.002). Renal function (mean eGFR)
significantly increased 71.3  5.8 to 79.4  5.1
(p0.011). Long term outcomes: Freedom from recurrent
hypertension (140 SBP and90DBP) was (95, 75, 43%)
and freedom from renal failure was (100, 95, 65%) at 1, 5
and 8 years, respectively. Patients with reduced baseline
renal function (60) were more likely to experience long
term renal failure (p0.003). Primary and assisted primary
patency was (95, 71, 50%) and (100, 97, 97%) at 1, 5, and
9 years, respectively.
Conclusions: Angioplasty is a feasible and durable tool
for treating FMD. Early intervention may be imperative to
achieve renal function salvage. Short and long term out-
comes are promising.
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Video Presentation
Surgical Treatment of Nutcracker Syndrome: Left Re-
nal Vein Transposition with Vein Cuff Interposition
Magdiel Trinidad Hernandez, Peter Gloviczki. Vascular
and Endovascular Surgery, Mayo Clinic, Rochester, MN
Background: Nutcracker syndrome is caused by com-
pression of the left renal vein (LRV) between the aorta and
the superior mesenteric artery (SMA) resulting in gonadal
and left renal venous hypertension. We present our tech-
nique of LRV transposition for the management of Nut-
cracker syndrome in a 23 year-old female who presented
with hematuria and relentless left flank pain requiring opi-
ate analgesics. This technique offers a solution when the
LRV is too short to be transposed tension-free.
Technical Description: The patient underwent a
midline laparotomy. The retroperitoneum was incised
and the LRV and IVC were dissected free. The left
adrenal vein and various small branches were ligated.
Despite this, the LRV alone was not long enough to be
transposed caudally onto the IVC without tension.
Therefore, a segment of Great Saphenous vein was har-
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vested and spliced longitudinally to be used as an inter-
position cuff between the IVC and LRV. A partial-
occlusion clamp was then placed across the IVC-LRV
junction. The LRV was divided and the venotomy on the
IVC was extended inferiorly. The superior portion of the
IVC venotomy was sutured. Subsequently, the LRV was
then anastomosed caudally onto the IVC in and end-to-
side fashion with the vein cuff bridging the gap.
Author Disclosures: P. Gloviczki: Nothing to disclose;
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Management of the Acutely Ischemic Limb in the In-
fant Population: Evidence for Non-operative Manage-
ment
Jesus M. Matos, Andres Fajardo, Michael C. Dalsing,
Raghu L. Motaganahalli, George A. Akingba, Gary W.
Lemmon, Michael P. Murphy. Indiana University School
of Medicine, Indianapolis, IN
Objectives: Acute limb ischemia (ALI) in infants is a
catastrophic event usually associated with other life
threatening medical problems. Since ALI is rare in the
infant population it presents a clinical conundrum for the
vascular surgeon with regards to management. Here we
report our experience in the management of infant ALI
to provide management guidelines for the vascular
surgeon.
Methods: Retrospective analysis of our vascular sur-
gery database from 2004 - 2010 of infants diagnosed with
ALI.
Results: Twelve infants with a mean age of 3  3
months were identified. There were 11 iatrogenic injuries
and 1 unknown cause of ALI. The most frequent presen-
tations were cyanotic limbs (n8) and pulselessness (n6).
The lower extremities were most commonly involved
(n9). The most common arterial sites of occlusion were
CFA (n6), SFA (n3), and radial arteries (n2).
Eleven patients were treated conservatively with systemic
heparin (n8), intra-muscular enoxaparin (n2) and
anti-platelet treatment (n1). One patient was treated
surgically with Fogarty balloon thrombectomy of the
CFA. There were three deaths all due to associated
comorbidities. The one surgically managed patient died
30 days after intervention due to septic complications.
Follow up was available on seven of nine survivors. All
had palpable pulses present and viable limbs on fol-
low-up examination (mean 20  14 months, range
5-42). There were three complications in the patients
managed conservatively: loss of fingernails (1), skin ne-
crosis requiring debridement (1), and maldevelopment
of the foot (1). None of the patients required amputa-
tion due to conservative management.
Conclusions: Limb viability was 100% in this series of
infant ALI managed non-operatively, which reflects the po-
tential of collateral vessel formation and recanalization of
thrombosed vessels in this patient population. Our recom-
mendation for infants presenting with ALI is conservative
observation with anti-coagulation and intervention only for
cases with tissue loss.
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Long-term Benefit of Perioperative Statin Use in Pa-
tients Undergoing Vascular Surgery: Results from the
DECREASE III Trial
Olaf Schouten, Sanne E. Hoeks, Michiel T. Voute, Eric
Boersma, Hence J. Verhagen, Don Poldermans. Erasmus
MC, Rotterdam, Netherlands
Objectives: The randomized DECREASE III trial
showed that perioperative statin use is associated with a
significant reduction of perioperative cardiovascular
events. However, the potential long-term benefit of
starting statins preoperatively is not well described. The
aim of this study was to establish whether preoperative
initation of statin therapy also results in a long-term
survival benefit compared to postoperative initiation of
statin therapy.
Methods: The DECREASE III trial was a double blind
randomized trial including vascular surgery patients, compar-
ing placebo and fluvastatin use in the perioperative period.
Treatment started amedian of 34 days prior to surgery. At the
end of the study period, i.e. at the outpatient clinic visit 30
days after surgery, all patients were prescribed life-long statins
as recommended by current guidelines. The endpoint of the
current analysis was all-cause death, ascertained by contacting
the civil service registry.
Figure 1. Long-term outcome of patients on perioperative statin
therapy vs placebo.
JOURNAL OF VASCULAR SURGERY
June Supplement 201120S Abstracts
